He Sold His First Startup to Roche for $425 Million And Now is Bringing Targeted Therapies To Critically Ill Patients

“Jason Springs has been tackling the greatest threats to modern healthcare for the past 15 years. His first startup was bought in a deal valued at over $400M, and he’s now on his second and even larger venture.”

Click here and see full article.